Zankiren

Known as: (S)-N-((1S,2R,3S)-1-(Cyclohexylmethyl)-2,3-Dihydroxy-5-Methylhexyl)-Alpha((Alpha-S)-Alpha(((4-Methyl-1-Piperazinyl)Sulfonyl)Methyl)Hydrocinnamamido)-4-Thiazolepropionamide, 4-Thiazolepropanamide, N-(1-(Cyclohexylmethyl)-2,3-Dihydroxy-5-Methylhexyl)-Alpha-((2-(((4-Methyl-1-Piperazinyl)Sulfonyl)Methyl)-1-Oxo-3-Phenylpropyl)Amino)-, (1S-(1R*,(R*(R*)),2S*,3R*))- 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1995-2015
01219952015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
We investigate the binding mechanism in renin complexes, involving three drugs (remikiren, zankiren and enalkiren) and one lead… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • figure 5
Is this relevant?
Review
2012
Review
2012
Standard treatments available today for treating hypertension is diuretics, β-blockers, angiotensin converting enzyme inhibitors… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
OBJECTIVES Aliskiren is a new renin inhibitor of a novel structural class that has recently been shown to be efficacious in… (More)
Is this relevant?
1995
1995
Renin inhibition represents an alternative to angiotensin-converting enzyme (ACE) inhibition for pharmacologic interruption of… (More)
Is this relevant?
1995
1995
BACKGROUND Zankiren HCl (A-72517) is a potent renin inhibitor shown to have substantial bioavailability in several animal species… (More)
Is this relevant?